VIVIAN HUNT: Open Payments
NPI 1073109948 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,942 in 47 payments from 11 companies in 2025. Trend: 2023 $1,756 · 2024 $3,298 · 2025 $3,942
Consulting: $1,924Food & beverage: $1,854Education: $164
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $1,550 |
| LEO Pharma Inc. | 2 | $845 |
| Janssen Biotech, Inc. | 11 | $656 |
| Arcutis Biotherapeutics, Inc. | 3 | $307 |
| ABBVIE INC. | 14 | $277 |
| Regeneron Healthcare Solutions, Inc. | 2 | $149 |
| Amgen Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Smith+Nephew, Inc. | 1 | $18 |
Products named: TREMFYA, Zoryve, Sotyktu, SKYRIZI, DUPIXENT, OTEZLA, RINVOQ, Rhapsido.
Industry payments across KY — which companies pay providers there.
